Form 3 - Initial statement of beneficial ownership of securities

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

GlucoTrack (NASDAQ:GCTK)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more GlucoTrack Charts.

GlucoTrack (NASDAQ:GCTK)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more GlucoTrack Charts.

GlucoTrack Inc News

Form 8-K - Current report
Saturday 15 February 2025 (3 days ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 6 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 6 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
Wednesday 5 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 5 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Wednesday 5 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 31 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Glucotrack Announces Reverse Stock Split
Friday 31 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 30 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
Thursday 30 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 22 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Glucotrack Announces ISO 13485:2016 Certification
Wednesday 22 January 2025 (4 weeks ago) • GlobeNewswire Inc.

More GlucoTrack Inc News Articles

BNP Paribas Issuance

World Bank Sustain Fx 4....

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions